Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
A mixture of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
EC number: 403-720-7 | CAS number: 117527-94-3 NOIR ORASOL 9342A; NOIR ORASOL RLI; ORASOL BLACK 9342A; ORASOL BLACK RLI; SAVINYL NOIR 2R
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro
Ames test:
The mutagenicity of the test substance was evaluated in the standard Ames test according to OECD TG 471 and GLP in the bacteria strains TA 1535, TA 1537, TA 98 and TA 100 of S. thyphimurium. The test substance was tested both in the presence and absence of metabolic activation (S9 mix from induced rat liver) at concentrations of 100, 333, 1000, 3330 and 5000 µg/plate. A preliminary toxicity test was carried out in the tester strain TA100 with concentrations ranging from 1 to 5000 µg/plate, from which it was concluded that 5000mg/plate could be used as the highest concentration. 0.1 ml DMSO/plate was used as solvent control. Three Petri dishes were prepared per strain per concentration and in order to confirm the results, the experiments were repeated. In the mutagenicity assay the test substance induced a 5 to 45 fold increase in the number of revertant (His+) colonies in the tester strains TA1537, TA98 and TA100 both in the absence and presence of S9-mix in two independent experiments. Tester strain TA1535 was considered negative in both experiments. The positive controls gave the expected results. Based on the results of this study it was concluded that the test substance can be considered as mutagenic in the Ames test.
Chromosome aberration test:
In a mammalian cell cytogenetics assay according to OECD TG 473 and GLP, the test substance formulated in acetone was assessed for its potential to induce structural chromosome aberrations in V79 cells up to cytotoxic and/or precipitating concentrations in the absence and the presence of metabolic activation by S9 mix. Two independent experiments were performed, each set up with two parallel cultures, in which the first experiment included an exposure time of 18 hrs and the second a exposure and/or harvest time of 28 hrs. Per culture at least 100 metaphase plates were scored for structural chromosome aberrations. The concentrations of the test substance in both experiments ranged from 0 to 350 µg/mL depending on the exposure time and the use of metabolic activation. The concentrations used were chosen according to an initial range–finding cytotoxicity test. The negative controls (vehicle controls) gave frequencies of aberrations within the range expected for the V79 cell line. Both of the positive controls, i.e. cyclophosphamide and ethylmethanesulfonate, led to the expected increase in the number of cells containing structural chromosomal aberrations. The test substance did not cause any increase in the number of structurally aberrant metaphases incl. and excl. gaps in both experiments, with and without a metabolizing system. In addition no increase in the frequency of cells containing numerical aberrations was noted. In conclusion, it can be stated that under the experimental conditions reported, the test substance did not induce structural chromosome abberations in V79 cells when tested up to cytotoxic and/or precipitating concentrations.
Mammalian Cell Gene Mutation test:
In a cell gene mutation assay in accordance with OECD TG 476 and under GLP, the potential of the test substance to induce mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus using the cell line V79 was investigated. The treatment period was 4h in two independent experiments (each with duplicate cultures) at concentrations of 6; 10; 15; and 20 µg/ml with metabolic activation and concentrations of 6; 10; 30; 60 and 100 µg/ml without metabolic activation. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive andvalid. No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both main experiments. Cytotoxic effects were observed in the absence of metabolic activation (relative plating efficiency of 84.8%, 80.5% and 49.1% at 10, 15 and 20 µg/ml, respectively), whereas with metabolic activation no cytotoxicity was seen up to the highest test concentration of 100 µg/ml.Higher concentrations precipitated in the culture medium. In conclusion it can be stated that under the experimental conditions the test substance did not induce mutations in the HPRT-locus with or without metabolic activation.
In vivo
Micronucleus test:
In a micronucleus test in accordance with OECD TG 474 and GLP in Swiss mice (5 animals/sex/ dose) the test substance was dosed once by gavage at 5000 mg/kg bw. The dose was selected based on the results in a preliminary toxicty study. The dosing volume was 10 ml/kg bw and corn oil was used as vehicle. Bone marrow cells were harvested 24, 48 and 72 hours (negative control and all dose levels) and 48 hours post-treatment (for positive control). There were no signs of toxicity during the study. The test substance did not cause any significant decreases in the ratio of polychromatic to normochromatic erythrocytes at the 24, 48 and 72 hour sampling time. No significant increase in the frequency of micronucleated erythrocytes in bone marrow at a dose of 5000 mg/kg bw after treatment with the test substance was observed. The positive control cyclophosphamide induced the appropriate response. In conclusion the test substance was found to be not clastogenic or aneugenic in this test.Short description of key information:
The test substance was found to be positive in the standard Ames test (OECD 471, GLP). No genotoxic potential was found in the Chromosomal Abberation Test in vitro (OECD 473, GLP), in the Mammalian Cell Gene Mutation Test in vitro (OECD 476, GLP) and in the Erythrocyte Micronucleus Test in vivo (OECD 474, GLP).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The test substance was found to be positive in the standard Ames test. However, no genotoxic potential was found in the Chromosomal Abberation Test in vitro, in the Mammalian Cell Gene Mutation Test in vitro and in the Erythrocyte Micronucleus Test in vivo. Based on these results, the test substance does not need to be classified and labelled for mutagenicity according to Directive 67/548/EEC and Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.